Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aarhus University Hospital
Beta-blockers, ACE inhibitors, calcium-channel blockers are associated with reduced fracture risk
May 8th, 2006
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a small but significantly reduced risk of fracture. Investigators publishing in the Journal of Hypertension note, "Cardiovascular diseases are associated with disturbances in calcium metabolism, including increased urinary calcium, vitamin D insufficiency, and decreased bone mineral density. Antihypertensive drugs may increase the risk of falling. However, risk of fracture in patients treated with non-diuretic cardiovascular drugs is largely unknown." Aarhus University Hospital researchers L. Rejnmark and colleagues explained, "We investigated...
Source: Biotech Week (2006-05-08)
|
